ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 133 filers reported holding ARRAY BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is 16.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $48,760,000 | +36.9% | 2,000,000 | -20.0% | 1.99% | +50.9% |
| Q4 2018 | $35,625,000 | +23.4% | 2,500,000 | +31.6% | 1.32% | +75.6% |
| Q3 2018 | $28,880,000 | -13.9% | 1,900,000 | -5.0% | 0.75% | +5.3% |
| Q2 2018 | $33,560,000 | +2.8% | 2,000,000 | 0.0% | 0.71% | +74.8% |
| Q1 2018 | $32,640,000 | +27.5% | 2,000,000 | 0.0% | 0.41% | +5.4% |
| Q4 2017 | $25,600,000 | -16.7% | 2,000,000 | -20.0% | 0.39% | -27.0% |
| Q3 2017 | $30,750,000 | +153.4% | 2,500,000 | +72.4% | 0.53% | +150.0% |
| Q2 2017 | $12,137,000 | +81.0% | 1,450,000 | +93.3% | 0.21% | +42.3% |
| Q1 2017 | $6,705,000 | -39.0% | 750,000 | -40.0% | 0.15% | -38.9% |
| Q4 2016 | $10,988,000 | -53.5% | 1,250,000 | -64.3% | 0.24% | -47.9% |
| Q3 2016 | $23,625,000 | +71.5% | 3,500,000 | -9.6% | 0.47% | +64.8% |
| Q2 2016 | $13,777,000 | +25.9% | 3,870,000 | +4.3% | 0.28% | +32.7% |
| Q1 2016 | $10,945,000 | -35.3% | 3,710,000 | -7.5% | 0.21% | -32.7% |
| Q4 2015 | $16,922,000 | -7.5% | 4,010,000 | 0.0% | 0.32% | -22.2% |
| Q3 2015 | $18,286,000 | -36.8% | 4,010,000 | 0.0% | 0.41% | -67.1% |
| Q2 2015 | $28,912,000 | +5.7% | 4,010,000 | +8.1% | 1.24% | -1.6% |
| Q1 2015 | $27,343,000 | +74.6% | 3,710,000 | +12.1% | 1.26% | +130.2% |
| Q4 2014 | $15,656,000 | +46.2% | 3,310,000 | +10.3% | 0.55% | +39.3% |
| Q3 2014 | $10,710,000 | -21.7% | 3,000,000 | 0.0% | 0.39% | -28.8% |
| Q2 2014 | $13,680,000 | -3.0% | 3,000,000 | 0.0% | 0.55% | +8.4% |
| Q1 2014 | $14,100,000 | -6.2% | 3,000,000 | 0.0% | 0.51% | -5.4% |
| Q4 2013 | $15,030,000 | -19.5% | 3,000,000 | 0.0% | 0.54% | -11.2% |
| Q3 2013 | $18,660,000 | +37.0% | 3,000,000 | 0.0% | 0.61% | +41.5% |
| Q2 2013 | $13,620,000 | – | 3,000,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |